The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Assembly Biosciences, Inc(NASDAQ:ASMB) 
Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Its product candidates include Vebicorvir to treat patients with chronic HBV infection; ABI-H21...
Website: http://www.assemblybio.com
Founded: 2005
Full Time Employees: 140
Sector: Healthcare
Industry: Biotechnology
Assembly Biosciences Days Payable Outstanding ttm (DPO)
Assembly Biosciences Days Receivable Outstanding ttm (DSO)
Assembly Biosciences Days Inventory Outstanding ttm (DIO)
Assembly Biosciences Op Cashflow Per Share ttm
Assembly Biosciences Free Cashflow Per Share ttm
Assembly Biosciences Cash Per Share ttm
Assembly Biosciences P/S ratio ttm
Assembly Biosciences (GAAP) P/E ratio ttm
Assembly Biosciences P/B ratio ttm
No extra charts and metrics for this ticker.